Monthly Archives: December 2014

European Reference Networks

The newly launched “European Reference Networks” Program has recently focused its organisational activities by assembling their first Board meeting on December 5th, which rounded up the official representatives of the Member States. The resolutions of this event involved electing a chairperson and approving regulatory procedures. ERNs are a feature of the EU Directive on Cross-border [...]

By |2017-01-03T11:18:12+00:00December 30th, 2014|News|

European Medicines Agency policy on publication of clinical data

In October 2014, the European Medicines Agency (EMA) Board adopted the wording of the Agency’s new policy intended to further increase the availability of clinical trials data for medicinal products authorised in the EU: European Medicines Agency policy on publication of clinical data for medicinal products for human use Q&A on the European Medicines Agency [...]

By |2015-11-26T15:42:19+00:00December 30th, 2014|News|

NEOMERO1 Clinical Trial Status

The core strategy of the NEOMERO Project includes the combination of two clinical trials: Neomero1 (an open-label, randomised, multicenter, comparator-controlled study to evaluate the PK, efficacy and safety of meropenem as compared with standard antibiotic therapy in neonates and infants aged < 3 months treated in neonatal intensive care units (NICU) for late onset sepsis [...]

By |2015-11-26T15:48:55+00:00December 27th, 2014|News|

“G. Benzi” Biennial Master’s Program in Regulatory Sciences

The University of Pavia has launched the eleventh edition of the “G. Benzi” Biennial II level Master’s Program in Regulatory Science. The deadline for the submission of applications is January 15th, 2015. Please see the following references (ITA) for more information: Call for applications to the University of Pavia master’s programs Regulatory Sciences Master’s Program [...]

By |2015-11-26T17:00:57+00:00December 5th, 2014|News|

Newsletter

Sign-up to get the latest news and update information. Don’t worry, we won’t send spam!

Go to Top